CA2510446C - Genes conferring herbicide resistance - Google Patents

Genes conferring herbicide resistance Download PDF

Info

Publication number
CA2510446C
CA2510446C CA2510446A CA2510446A CA2510446C CA 2510446 C CA2510446 C CA 2510446C CA 2510446 A CA2510446 A CA 2510446A CA 2510446 A CA2510446 A CA 2510446A CA 2510446 C CA2510446 C CA 2510446C
Authority
CA
Canada
Prior art keywords
seq
plant
sequence
nucleotide sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2510446A
Other languages
French (fr)
Other versions
CA2510446A1 (en
Inventor
Philip E. Hammer
Nicholas B. Duck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Athenix Corp
Original Assignee
Athenix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2510446(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Athenix Corp filed Critical Athenix Corp
Publication of CA2510446A1 publication Critical patent/CA2510446A1/en
Application granted granted Critical
Publication of CA2510446C publication Critical patent/CA2510446C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C12N15/8275Glyphosate

Abstract

Compositions and methods for conferring herbicide resistance to plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a polypeptide that confers resistance or tolerance to glyphosate herbicides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants. Compositions also comprise transformed plants, plant cells, tissues, and seeds. In particular, isolated nucleic acid molecules corresponding to glyphosate resistant nucleic acid sequences are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID N0:2 or the nucleotide sequence set forth in SEQ ID NO: 1.

Description

GENES CONFERRTNG HERBICIDE RESISTANCE
FIELD OF THE INVENTION
This invention provides novel genes encoding herbicide resistance, which are useful in plant biology, crop breeding, and plant cell culture.
BACKGROUND OF THE INVENTION
N-phosphonomethylglycine, commonly referred to as glyphosate, is an important agronomic chemical. Glyphosate inhibits the enzyme that converts phosphoenolpyruvic acid (PEP) and 3-phosphoshikimic acid to 5-enolpyruvyl-3-phosphoshikimic acid. Inhibition of this enzyme (5-enolpyruvylshikimate-3-phosphate synthase; referred to herein as "EPSP synthase") kills plant cells by shutting down the shikimate pathway, thereby inlubiting aromatic acid biosynthesis.
Since glyphosate-class herbicides inhibit aromatic amino acid biosynthesis, they not only kill plant cells, but are also toxic to bacterial cells.
Glyphosate inhibits many bacterial EPSP syntheses, and thus is toxic to these bacteria. However, certain bacterial EPSP syntheses have high tolerances to glyphosate. Several such bacterial EPSP synthase have been previously isolated. Analysis of the existing sequences of glyphosate resistant and sensitive EPSP syntheses does not predict a priori whether a given EPSP synthase is glyphosate resistant or glyphosate sensitive, or the level of resistance of any amino acid sequence to glyphosate inhibition. Furthermore, the sequences of knovv~l EPSP syntheses do not predict all sequences capable of functioning to encode EPSP synthase activity, nor the level of resistance to glyphosate of that amino acid sequence.
Plant cells resistant to glyphosate toxicity can be produced by transfoi-tning plant cells to express glyphosate-resistant bacterial EPSP syntheses. Notably, the bacterial gene from Agrobacterium tumefaciesas strain CP4 has been used to confer herbicide resistance on plant cells following expression in plants. A mutated EPSP
synthase from Salmonella typhimus-ium strain CT7 confers glyphosate resistance in bacterial cells, and confers glyphosate resistance on plant cells (IJ.S.
Patent Nos.

4,535,060; 4,769,061; and 5,094,945). However, there is a need for other herbicide resistance genes.
SUNIIVIARY OF INVENTION
Compositions and methods for conferring herbicide resistance to plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a polypeptide that confers resistance or tolerance to glyphosate herbicides are provided. The coding sequences can be used in DNA constructs ox expression cassettes for transformation and expression in plants and other organisms.
Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds.
In particular, isolated nucleic acid molecules corresponding to glyphosate resistant nucleic acid sequences are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID N0:2 or the nucleotide sequence set forth in SEQ ID NO:1 and mutants and variants thereof.
DESCRIPTION OF FIGURES
Figure 1 shows an aligmnent of GRG-1 protein (SEQ ll~ NO:2) to related proteins.
Figures 2A and B show an alignment of GRG-1 protein (SEQ ID N0:2) to related proteins.
Figures 3A, B, and C show an alignment of the GRG-1 protein (SEQ ID
N0:2) to related proteins.
DETAILED DESCRIPTION
The present invention is drawn to compositions and methods for regulating herbicide resistance in organisms, particularly in plants or plant cells. The methods involve transforming organisms with nucleotide sequences encoding the glyphosate resistance gene of the invention. In particular, he nucleotide sequences of the invention are useful for preparing plants that show increased tolerance to the herbicide glyphosate. Thus, transformed plants, plant cells, plant tissues and seeds are provided. Compositions of the invention comprise nucleic acids and proteins relating to glyphosate tolerance in plants. More particularly, nucleotide sequences of the glyphosate resistance gene (GRG) and the amino acid sequences of the proteins encoded thereby are disclosed. The sequences fmd use in the construction of expression vectors for subsequent transformation into plants of interest, as probes for the isolation of other glyphosate resistance genes, as selectable markers, and the like.
Definitions "Glyphosate" includes any herbicidal form of N-phosphonomethylglycine (including any salt thereof) and other forms which result in the production of the glyphosate anion ih planta. "Glyphosate resistance gene" or "GRG" or "glyphosate resistance encoding nucleic acid sequence" includes a DNA segment that encodes all or part of a glyphosate resistance protein. This includes DNA segments that are capable of expressing a glyphosate resistance protein in a cell, such as a gene.
A "glyphosate resistance protein" includes a protein that confers upon a cell the ability to tolerate a higher concentration of glyphosate than cells that do not express this protein, or to tolerate a certain concentration of glyphosate for a longer ' time than cells that do not express this protein. This ability to survive in the presence of glyphosate is due to the protein having "glyphosate resistance activity."
By "tolerate" is intended to survive, or to carxy out essential cellular functions such as protein synthesis and respiration.
"Plant cell" includes all known forms of a plant, including undifferentiated tissue (e.g. callus), suspension culture cells, protoplasts, leaf cells, root cells, phloem cells, plant seeds, pollen, propagules, embryos and the like. "Plant expression cassette" includes DNA constructs that are capable of resulting in the expression of a protein from an open reading frame in a plant cell. Typically these contain a promoter and a gene. Often, such constructs will also contain a 3'untranslated region.
It is understood that if a construct does not per se contain a 3' transcription termination signal, that transcription will be terminated nonetheless, via recognition by the transcription apparatus of the most closely located acceptable sequence.
Often, such constructs may contain a 'signal sequence' or 'leader sequence' to facilitate co-translational or post-translational transport of the peptide to certain intracellular structures such as the chloroplast (or other plastid), endoplasmic reticulum, or Golgi apparatus.
"Signal sequence" includes sequences that are known or suspected to result in cotranslational or post-translational peptide transport across the cell membrane. In eukaryotes, this typically involves secretion into the Golgi apparatus, with some resulting glycosylation. "Leader Sequence" includes any sequence that when translated, results in an amino acid sequence sufficient to trigger co-translational transport of the peptide chain to a sub-cellular organelle. Thus, this includes leader sequences targeting transport and/or glycosylation by passage into the endoplasmic reticulum, passage to vacuoles, plastids including chloroplasts, mitochondria, and the like.
"Plant transformation vector" includes DNA molecules that are necessary for efficient transformation of a plant cell. Such a molecule may consist of one or more plant expression cassettes, and may be organized into more than one 'vector' DNA
molecule. For example, binary vectors are plant transformation vectors that utilize two non-contiguous DNA vectors to encode all requisite cis- and trans-acting functions for transformation of plant cells (Hellens and Mullineaux (2000) Trends in Plah.t Science 5:446-451).
"Vector" refers to a nucleic acid construct designed for transfer between different host cells. "Expression vector" refers to a vector that has the ability to incorporate, integrate and express heterologous DNA sequences or fragments in a foreign cell.
"Transgenic plants" or "transformed plants" or "stably transformed plants or cells or tissues" refers to plants that have incorporated or integrated exogenous nucleic acid sequences or DNA fragments that are not present in the i.e.
"untransformed" plant or plant cell.
"Heterologous" generally refers to the nucleic acid sequences that are not endogenous to the cell or part of the native genome in which they are present, and have been added to the cell by infection, transfection, microinjection, electroporation, microprojection, or the like.
"Promoter" refers to a nucleic acid sequence that functions to direct transcription of a downstream gene. The promoter together with other transcriptional and translational regulatory nucleic acid sequences (also termed as "control sequences") are necessary for the expression of a gene of interest.
Provided herein is a novel gene that confers resistance to glyphosate. Further provided is the DNA sequence of this gene. Also provided is the amino acid sequence of the GRG-1 protein. The protein resulting from translation of this gene allows cells to function in the presence of concentrations of glyphosate that are otherwise toxic to cells including plant cells and bacterial cells.
Preferred glyphosate resistance proteins of the present invention have an amino acid sequence sufficiently identical to the amino acid sequence of SEQ m N0:2. The term "sufficiently identical" is used herein to refer to a first amino acid or nucleotide sequence that contains a sufficient or minimum number of identical or equivalent (e.g., with a similar side chain) amino acid residues or nucleotides to a second amino acid or nucleotide sequence such that the first and second amino acid or nucleotide sequences have at least about 45%, about 55%, or about 65%
identity, preferably about 75% identity, more preferably about 85%, most preferably about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% identity.
Sequences that are sufficiently identical will have a common functional activity and may have one or more common structural domains or motifs, such as those shown in Figures 3A, B and C. Functional activity of herbicide resistance proteins may be determined by methods known in the art. See, for example, Osuna et al. (2001) Pest MafZag. Sci. 59:1210-1216; Ye et al. (2001) Playlt J. 25:261-270.
To determine the percent identity of two amino acid sequences or of two nucleic acids, the sequences are aligned for optimal comparison purposes. The percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e., percent identity = number of identical positions/total number of positions (e.g., overlapping positions) x 100). In one embodiment, the two sequences are the same length. The percent identity between two sequences can be determined using techniques similar to those described below, with or without allowing gaps. In calculating percent identity, typically exact matches are counted.
The determination of percent identity between two sequences can be accomplished using a mathematical algorithm. A preferred, nonlimiting example of a mathematical algorithm utilized for the comparison of two sequences is the algorithm of Karlin and Altschul (1990) Py~oc. Natl. Acad. Sci. USA 87:2264, modified as in Karlin and Altschul (1993) P~oc. Natl. Acad. Sci. ZISA 90:5873-5877. Such an algorithm is incorporated into the BLASTN and BLASTX programs of Altschul et al.
(1990) J. Mol. Biol. 215:403. BLAST nucleotide searches can be performed with the BLASTN program, score = 100, wordlength = 12, to obtain nucleotide sequences homologous to GRG-like nucleic acid molecules of the invention. BLAST protein searches can be performed with the BLASTX program, score = 50, wordlength = 3, to obtain amino acid sequences homologous to glyphosate resistance protein molecules of the invention. To obtain gapped alignments for comparison purposes, Gapped BLAST can be utilized as described in Altschul et al. (1997) Nucleic Acids Res.
25:3389. Alternatively, PSI-Blast can be used to perform an iterated search that detects distant relationships between molecules. See Altschul et al. (1997) supra.
When utilizing BLAST, Gapped BLAST, and PSI-Blast programs, the default parameters of the respective programs (e.g., BLASTX and BLASTN) can be used.
See www.ncbi.nlm.nih.gov. Another preferred, non-limiting example of a mathematical algorithm utilized for the comparison of sequences is the ClustalW
algorithm (Higgins et al. (1994) Nucleic Acids Res. 22:4673-4680). ClustalW
compares sequences and aligns the entirety of the amino acid or DNA sequence, and thus can provide data about the sequence conservation of the entire amino acid sequence. The ClustalW algorithm is used in several commercially available DNA/amino acid analysis software packages, such as the ALIGNX module of the vector NTi Program Suite (Informax, Inc). After alignment of amino acid sequences with ClustalW, the percent amino acid identity can be assessed. A non-limiting example of a software program useful for analysis of ClustalW alignments is GeneDocTM. GenedocTM (Karl Nicholas) allows assessment of amino acid (or DNA) similarity and identify between multiple proteins. Another preferred, non-limiting example of a mathematical algorithm utilized for the comparison of sequences is the algorithm of Myers and Miller (1988) CABIOS 4:11-17. Such an algorithm is incorporated into the ALIGN program (version 2.0), which is part of the GCG
sequence alignment software package. When utilizing the ALIGN program for comparing amino acid sequences, a PAM120 weight residue table, a gap length penalty of 12, and a gap penalty of 4 can be used.
An "isolated" or "purified" nucleic acid molecule or protein, or biologically active portion thereof, is substantially free of other cellular material, or culture medium when produced by recombinant techniques, or substantially free of chemical precursors or other chemicals when chemically synthesized. Preferably, an "isolated"
nucleic acid is free of sequences (preferably protein encoding sequences) that naturally flank the nucleic acid (i.e., sequences located at the 5' and 3 ends of the nucleic acid) in the genomic DNA of the organism from which the nucleic acid is derived. For purposes of the invention, "isolated" when used to refer to nucleic acid molecules excludes isolated chromosomes. For example, in various embodiments, the isolated glyphosate resistance encoding nucleic acid molecule can contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb, or 0.1 kb of nucleotide sequences that naturally flank the nucleic acid molecule in genomic DNA of the cell from which the nucleic acid is derived. A glyphosate resistant protein that is substantially free of cellular material includes preparations of protein having less than about 30%, 20%, 10%, or 5% (by dry weight) of non-glyphosate resistant protein (also referred to herein as a "contaminating protein"). Various aspects of the invention are described in further detail in the following subsections.
Isolated Nucleic Acid Molecules One aspect of the invention pertains to isolated nucleic acid molecules comprising nucleotide sequences encoding glyphosate resistance proteins and polypeptides or biologically active portions thereof, as well as nucleic acid molecules sufficient for use as hybridization probes to identify glyphosate resistance encoding nucleic acids. As used herein, the term "nucleic acid molecule" is intended to include DNA molecules (e.g., cDNA or genomic DNA) and RNA molecules (e.g., mRNA) and analogs of the DNA or RNA generated using nucleotide analogs. The nucleic acid molecule can be single-stranded or double-stranded, but preferably is double-stranded DNA.
Nucleotide sequences encoding the proteins of the present invention include sequences set forth in SEQ ID NO:l and complements thereof. By "complement" is intended a nucleotide sequence that is sufficiently complementary to a given nucleotide sequence such that it can hybridize to the given nucleotide sequence to thereby form a stable duplex. The corresponding amino acid sequence for the glyphosate resistance protein encoded by these nucleotide sequences is set forth in SEQ ID N0:2. The invention also encompasses nucleic acid molecules comprising nucleotide sequences encoding partial-length glyphosate resistance proteins, including the sequence set forth in SEQ m NO:1, and complements thereof.
Nucleic acid molecules that are fragments of these glyphosate resistance-encoding nucleotide sequences are also encompassed by the present invention.
By "fragment" is intended a portion of the nucleotide sequence encoding a glyphosate resistance protein. A fragment of a nucleotide sequence rnay encode a biologically active portion of a glyphosate resistance protein, or it may be a fragment that can be used as a hybridization probe or PCR primer using methods disclosed below.
Nucleic acid molecules that are fragments of a glyphosate resistance nucleotide sequence comprise at least about 15, 20, 50, 75, 100, 200, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250 nucleotides, or up to the number of nucleotides present in a full-length glyphosate resistance encoding nucleotide sequence disclosed herein (for example, 1293 nucleotides for SEQ m NO:l) depending upon the intended use.
A fragment of a glyphosate resistance encoding nucleotide sequence that encodes a biologically active portion of a protein of the invention will encode at least about 15, 25, 30, 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, or 400 contiguous amino acids, or up to the total number of amino acids present in a full-length glyphosate resistance protein of the invention (for example, 432 amino acids for the protein of the invention).
The invention also encompasses variant nucleic acid molecules. "Variants" of the glyphosate resistance encoding nucleotide sequences include those sequences that encode the glyphosate resistance proteins disclosed herein but that differ conservatively because of the degeneracy of the genetic code. These naturally occurring allelic variants can be identified with the use of well-known molecular biology techniques, such as polymerase chain reaction (PCR) and hybridization techniques as outlined below. Variant nucleotide sequences also include synthetically derived nucleotide sequences that have been generated, for example, by using site-directed mutagenesis but which still encode the glyphosate resistance proteins disclosed in the present invention as discussed below. Generally, nucleotide sequence variants of the invention will have at least about 45%, 55%, 65%, 75%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identity to a particular nucleotide sequence disclosed herein. A variant nucleotide sequence will encode a glyphosate resistance protein that has an amino acid sequence having at least about 45%, 55%, 65%, 75%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identity to the amino acid sequence of a glyphosate resistance protein disclosed herein. These variants will also retain functional activity, as determined by methods known in the art, such as these described in Example 8.
The skilled artisan will further appreciate that changes can be introduced by mutation into the nucleotide sequences of the invention thereby leading to changes in the amino acid sequence of the encoded glyphosate resistance proteins, without altering the biological activity of the proteins. Thus, variant isolated nucleic acid molecules can be created by introducing one or more nucleotide substitutions, additions, or deletions into the corresponding nucleotide sequence disclosed herein, such that one or more amino acid substitutions, additions or deletions are introduced into the encoded protein. Mutations can be introduced by standard techniques, such as site-directed mutagenesis and PCR-mediated mutagenesis. Such variant nucleotide 15, sequences are also encompassed by the present invention.
For example, preferably, conservative amino acid substitutions may be made at one or more predicted, preferably nonessential amino acid residues. A
"nonessential" amino acid residue is a residue that can be altered from the wild-type sequence of a glyphosate resistance protein without altering the biological activity, whereas an "essential" amino acid residue is required for biological activity.
A
"conservative amino acid substitution" is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan, histidine).
Amino acid substitutions maybe made in nonconserved regions, such as those shown in Figures 3A, B, and C, that retain function. In general, such substitutions would not be made for conserved amino acid residues, or for amino acid residues residing within a conserved motif, such as the residues shown in Table 6 where such residues are essential for protein activity. However, one of skill in the art would understand that functional variants may have minor conserved or nonconserved alterations in the conserved domains.
Alternatively, variant nucleotide sequences can be made by introducing mutations randomly along all or part of the coding sequence, such as by saturation mutagenesis, and the resultant mutants can be screened for ability to confer glyphosate resistance activity to identify mutants that retain activity.
Following mutagenesis, the encoded protein can be expressed recombinantly, and the activity of the protein can be determined using standard assay techniques.
Using methods such as PCR, hybridization, and the like corresponding glyphosate resistance sequences can be identified, such sequences having substantial identity to the sequences of the invention. See, for example, Sambrook J., and Russell, D.W. (2001) Moleculaf° Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) and Innis, et al. (1990) PCR
Protocols: A
Guide to Methods arad Applications (Academic Press, NY).
In a hybridization method, all or part of the glyphosate resistance nucleotide sequence can be used to screen cDNA or genomic libraries. Methods for construction of such cDNA and genomic libraries are generally known in the art and are disclosed in Sambrook and Russell, 2001, sups°a. The so-called hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled with a detectable group such as 32P, or any other detectable marker, such as other radioisotopes, a fluorescent compound, an enzyme, or an enzyme co-factor. Probes for hybridization can be made by labeling synthetic oligonucleotides based on the known glyphosate resistance-encoding nucleotide sequence disclosed herein. Degenerate primers designed on the basis of conserved nucleotides or amino acid residues in the nucleotide sequence or encoded amino acid sequence can additionally be used. The probe typically comprises a region of nucleotide sequence that hybridizes under stringent conditions to at least about 12, preferably about 25, more preferably about 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, or 400 consecutive nucleotides of glyphosate resistance-encoding nucleotide sequence of the invention or a fragment or variant thereof. Preparation of probes for hybridization is generally known in the art and is disclosed in Sambrook and Russell, 2001, supra, herein incorporated by reference.

In hybridization techW ques, all or part of a known nucleotide sequence is used as a probe that selectively hybridizes to other corresponding nucleotide sequences present in a population of cloned genomic DNA fragments or cDNA fragments (i.e., genomic or cDNA libraries) from a chosen organism. The hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled with a detectable group such as 32P, or any other detectable marker. Thus, for example, probes for hybridization can be made by labeling synthetic oligonucleotides based on the GRG sequence of the invention.
Methods for preparation of probes for hybridization and for construction of cDNA
and genomic libraries are generally known in the art and are disclosed in Sambrook et al. (1989) Molecular' Cloyaing: A Labo~atofy Nlaraual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, New York).
For example, the entire GRG sequence disclosed herein, or one or more portions thereof, may be used as a probe capable of specifically hybridizing to corresponding GRG-like sequences and messenger RNAs. To achieve specific hybridization under a variety of conditions, such probes include sequences that are unique and are preferably at least about 10 nucleotides in length, and most preferably at least about 20 nucleotides in length. Such probes may be used to amplify corresponding GRG sequences from a chosen organism by PCR. This technique may be used to isolate additional coding sequences from a desired organism or as a diagnostic assay to determine the presence of coding sequences in an organism.
Hybridization techniques include hybridization screening of plated DNA
libraries (either plaques or colonies; see, for example, Sambrook et al., 1989, supra).
Hybridization of such sequences may be carried out under stringent conditions. By "stringent conditions" or "stringent hybridization conditions"
is intended conditions under which a probe will hybridize to its target sequence to a detectably greater degree than to other sequences (e.g., at least 2-fold over background). Stringent conditions are sequence-dependent and will be different in different circumstances. By controlling the stringency of the hybridization and/or washing conditions, target sequences that are 100% complementary to the probe can be identified (homologous probing). Alternatively, stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are detected (heterologous probing). Generally, a probe is less than about nucleotides in length, preferably less than 500 nucleotides in length.
Typically, stringent conditions will be those in which the salt concentration is less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at. least about 60°C for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. Exemplary low stringency conditions include hybridization with a buffer solution of 30 to 35% formamide, 1 M NaCI, 1%
SDS (sodium dodecyl sulphate) at 37°C, and a wash in 1X to 2X SSC (20X
SSC = 3.0 M NaCI/0.3 M trisodium citrate) at 50 to 55°C. Exemplary moderate stringency conditions include hybridization in 40 to 45% formamide, 1.0 M NaCI, 1% SDS at 37°C, and a wash in 0.5X to 1X SSC at 55 to 60°C. Exemplary high stringency conditions include hybridization in 50% fonnamide, 1 M NaCl, 1% SDS at 37°C, and a wash in O.1X SSC at 60 to 65°C. Optionally, wash buffers may comprise about 0.1% to about 1% SDS. Duration of hybridization is generally less than about hours, usually about 4 to about 12 hours.
Specificity is typically the function of post-hybridization washes, the critical factors being the ionic strength and temperature of the final wash solution.
For DNA-DNA hybrids, the Tm can be approximated from the equation of Meinkoth and Wahl (1984) Araal. Biochem. 138:267-284: Tm = 81.5°C + 16.6 (log M) + 0.41 (%GC) -0.61 (% form) - 500/L; where M is the molarity of monovalent cations, %GC is the percentage of guanosine and cytosine nucleotides in the DNA, % form is the percentage of formarnide in the hybridization solution, and L is the length of the hybrid in base pairs. The Tm is the temperature (under defined ionic strength and pH) at which 50% of a complementary target sequence hybridizes to a perfectly matched probe. Tm is reduced by about 1 °C for each 1 % of mismatching; thus, Tm, hybridization, andlor wash conditions can be adjusted to hybridize to sequences of the desired identity. Fox example, if sequences with >90% identity are sought, the Tm can be decreased 10°C. Generally, stringent conditions are selected to be about 5°C lower than the thermal melting point (Tm) for the specific sequence and its complement at a defined ionic strength and pH. However, severely stringent conditions can utilize a hybridization and/or wash at 1, 2, 3, or 4°C lower than the thermal melting point (Tm);

moderately stringent conditions can utilize a hybridization and/or wash at 6, 7, 8, 9, or 10°C lower than the thermal melting point (Tm); low stringency conditions can utilize a hybridization andlor wash at 1 l, 12, 13, 14, 15, or 20°C lower than the thermal melting point (Tm). Using the equation, hybridization and wash compositions, and desired Tm, those of ordinary skill will understand that variations in the stringency of hybridization and/or wash solutions are inherently described. If the desired degree of mismatching results in a Tm of less than 45°C (aqueous solution) or 32°C (formamide solution), it is preferred to increase the SSC concentration so that a higher temperature can be used. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Labo~atoyy Teclaniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Acid Pf°obes, Part I, Chapter 2 (Elsevier, New York); and Ausubel et al., eds. (1995) Cuf°~erat Pfrotocols iya Molecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience, New York). See Sambrook et al., 1989, supy~a.
Isolated Proteins Glyphosate resistance proteins are also encompassed within the present invention. By "glyphosate resistance protein" or "glyphosate tolerant protein"
is intended a protein having the amino acid sequence set forth in SEQ ID NO: 2, as well as fragments, biologically active portions, and variants thereof.
"Fragments" or "biologically active portions" include polypeptide fragments comprising amino acid sequences sufficiently identical to the amino acid sequence set forth in SEQ ID N0:2 and that exhibit glyphosate resistance activity. A
biologically active portion of a glyphosate resistance protein can be a polypeptide which is, for example, 10, 25, 50, 100 or more amino acids in length. Such biologically active portions can be prepared by recombinant techniques and evaluated for glyphosate resistance activity. As used here, a fragment comprises at least about 8 contiguous amino acids of SEQ ID N0:2. The invention encompasses other fragments, however, such as any fragment in the protein greater than about 10, 20, 30, 50, 100, 150, 200, 250, and 300 amino.acids.
By "variants" is intended proteins or polypeptides having an amino acid sequence that is at least about 45%, 55%, 65%, preferably about 75%, about 85%, most preferably about 90%, about 91 %, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% identical to the amino acid sequence of SEQ ID N0:2, and that retain glyphosate resistance activity.
Variants also include polypeptides encoded by a nucleic acid molecule that hybridizes to the nucleic acid molecule of SEQ ID NO:1, or a complement thereof, under stringent conditions. Variants include polypeptides that differ in amino acid sequence due to mutagenesis.
GRG-1 is useful as a transformation reporter and selectable marker In one aspect of the invention, the GRG-1 gene is useful as a marker to assess transformation of bacterial or plant cells. Transformation of bacterial cells is accomplished by one of several techniques known in the art, not limited to electroporation, or chemical transformation (See for example Ausubel (ed.), Current Protocols in Molecular Biology, John Wiley and Sons, Inc. (1994)). Markers conferring resistance to toxic substances are useful in identifying transformed cells (having taken up and expressed the test DNA) from non-transformed cells (those not containing or not expressing the test DNA). By engineering GRG-1 to be (1) expressed from a bacterial promoter known to stimulate transcription in the organism to be tested, (2) properly translated to generate an intact GRG-1 peptide, and (3) placing the cells in an otherwise toxic concentration of glyphosate, one can identify cells that have been transformed with DNA by virtue of their resistance to glyphosate.
GRG-1 is useful as a selectable marker/reporter for plant transformation Transformation of plant cells can be accomplished in similar fashion. First, one engineers the GRG-1 gene in a way that allows its expression in plant cells.
Typically a construct that expresses such a protein would contain a promoter to drive transcription of the gene, as well as a 3'untranslated region to allow transcription termination and polyadenylation. The organization of such constructs is well known in the art. In some instances, it may be useful to engineer the gene such that the resulting peptide is secreted, or otherwise targeted within the plant cell.
For example, the gene can be engineered to contain a signal peptide to facilitate transfer of.the peptide to the endoplasmic reticulum. It may also be preferable to engineer the plant expression cassette to contain an intron, such that mRNA processing of the intron is required for expression.

Typically this 'plant expression cassette' will be inserted into a 'plant transformation vector'. This plant transformation vector may be comprised of one or more DNA vectors needed for achieving plant transformation. For example, it is a conunon practice in the art to utilize plant transformation vectors that are comprised of more than one contiguous DNA segment. These vectors are often referred to in the art as 'binary vectors'. Binary vectors as well as vectors with helper plasmids are most often used for Agrobacterium-mediated transformation, where the size and complexity of DNA segments needed to achieve efficient transformation is quite large, and it is advantageous to separate functions onto separate DNA
molecules.
Binary vectors typically contain a plasmid vector that contains the cis-acting sequences required for T-DNA transfer (such as left border and right border), a selectable marker that is engineered to be capable of expression in a plant cell, and a 'gene of interest' (a gene engineered to be capable of expression in a plant cell for which generation of transgenic plants is desired). Also present on this plasmid vector are sequences required for bacterial replication. The cis-acting sequences are arranged in a fashion to allow efficient transfer into plant cells and expression therein. Fox example, the selectable marker gene and the gene of interest are located between the left and right borders. Often a second plasmid vector contains the trans-acting factors that mediate T-DNA transfer from Agrobacterium to plant cells. This plasmid often contains the virulence functions (Vir genes) that allow infection of plant cells by Agrobacter-ium, and transfer of DNA by cleavage at border sequences and vir-mediated DNA transfer, as in understood in the art (Hellens and Mullineaux (2000) Tre3zds in Plafzt Scieface 5:446-451). Several types ofAgrobacteriunZ strains (e.g.
LBA4404, GV3101, EHA101, EHA105, etc.) can be used for plant transformation.
The second plasmid vector is not necessary for transforming the plants by other methods such as microprojection, microinjection, electroporation, polyethelene glycol, etc. Many types of vectors can be used to transform plant cells for achieving glyphosate resistance.
In general, plant transformation methods involve transferring heterologous DNA into tar-get plant cells (e.g. immature or mature.embryos, suspension cultures, undifferentiated callus, protoplasts, etc.), followed by applying a maximum threshold level of appropriate selection (depending on the selectable marker gene and in this case "glyphosate") to recover the transformed plant cells from a group of untransformed cell mass. Explants are typically transferred to a fresh supply of the same medium and cultured routinely. Subsequently, the transformed cells are differentiated into shoots after placing on regeneration medium supplemented with a maximum threshold level of selecting agent (e.g. "glyphosate"). The shoots are then S transferred to a selective rooting medium for recovering rooted shoots or plantlets.
The transgenic plantlets then grow into mature plants and produce fertile seeds (e.g.
Hiei et al. (1994) The Plant Journal 6:271-282; Ishida et al. (1996) Nature Biotechnology 14:745-7S0). Explants are typically transferred to a fresh supply of the same medium and cultured routinely. A general description of the techniques and methods for generating transgenic plantlets are found in Ayres and Park, 1994 (Cf°itical Reviews in Plant Science 13:219-239) and Bommineni and Jauhar, 1997 (Maydica 42:107-120). Since the transformed material contains many cells; both transformed and non-transformed cells are present in any piece of subj ected target callus or tissue or group of cells. The ability to kill non-transformed cells and allow 1 S transformed cells to proliferate results in transformed plant cultures.
Often, the ability to remove non-transformed cells is a limitation to rapid recovery of transformed plant cells and successful generation of transgenic plants.
Generation of transgenic plants may be performed by one of several methods, including but not limited to introduction of heterologous DNA by Agrobacteriufn into plant cells (Agrobacterium-mediated transformation), bombardment of plant cells with heterologous foreign DNA adhered to particles (particle bombardment), and various other non-particle direct-mediated methods (e.g. Hiei et al. (1994) The Plant Journal 6:271-282; Ishida et al. (1996) Nature Biotechnology 14:745-750; Ayres and Park (1994) Cf°itical Revieyvs irt Plarat ,Science 13:219-239;
Bommineni and Jauhar 2S (1997) Maydica 42:107-120) to transfer DNA.
Transformation protocols as well as protocols for introducing nucleotide sequences into plants may vary depending on the type of plant or plant cell, i.e., monocot or dicot, targeted for transformation. Suitable methods of introducing nucleotide sequences into plant cells and subsequent insertion into the plant genome 30- - include microinjection (Crossway et al. (1986) Biotechniques 4:320-334), electroporation (Riggs et al. (1986) Proc. Natl. Acaa'. Sci. USA 83:5602-5606, Agrobacterium-mediated transformation (IJ.S. Patent No. S,S63,OSS; U.S. Patent No.
5,981,840), direct gene transfer (Paszkowski et al. (1984) EMBO J. 3:2717-2722), and ballistic particle acceleration (see, for example, U.S. Patent No.
4,945,050; U.S.
Patent No. 5,879,918; U.S. Patent No. 5,886,244; U.S. Patent No. 5,932,782;
Tomes et al. (1995) "Direct DNA Transfer into Intact Plant Cells via Microprojectile Bombardment," in Plarat Cell, Tissue, and Orgara Culture: Fundamental Methods, ed.
Gamborg and Phillips (Springer-Verlag, Berlin); McCabe et al. (1988) Bioteclanology 6:923-926); and Lecl transformation (WO 00/28058). Also see Weissinger et al.
(1988) Ann. Rev. Genet. 22:421-477; Sanford et al. (1987) Particulate Science and Technology 5:27-37 (onion); Christou et al. (1988) Plant Playsiol. 87:671-674 (soybean); McCabe et al. (1988) BiolTechnology 6:923-926 (soybean); Finer and McMullen (1991) In Tlitro Cell Dev. Biol. 27P:175-182 (soybean); Singh et al.
(1998) Theor. Appl. Genet. 96:319-324 (soybean); Datta et al. {1990) Biotechnology 8:736-740 (rice); Klein et al. (1988) Proc. Natl. Acad. Sci. USA 85:4305-4309 (maize); Klein et al. (1988) Biotechnology 6:559-563 (maize); U.S. Patent No.
5,240,855; U.S. Patent Nos. 5,322,783 and 5,324,646; Tomes et al. (1995) 'Direct DNA Transfer into Intact Plant Cells via Microprojectile Bombardment," in Plant Cell, Tissue, and Organ Culture: Fundamental Methods, ed. Gamborg {Springer-Verlag, Berlin) (maize); Klein et al. (1988) Plant Physiol. 91:440-444 (maize);
Fromm et al. (1990) Biotechnology 8:833-839 (maize); Hooykaas-Van Slogteren et al. (1984) Nature (London) 311:763-764; U.S. Patent No. 5,736,369 (cereals);
Bytebier et al. (1987) Proc. Natl. Acad. Sci. USA 84:5345-5349 (Liliaceae); De Wet et al. (1985) in The Expej°imental Manipadation of Ovule Tissues, ed.
Chapman et al.
(Longman, New York), pp. 197-209 (pollen); Kaeppler et al. (1990) Plant Cell Reports 9:415-418 and Kaeppler et al. (1992) Tlaeor. Appl. Genet. 84:560-566 (whisker-mediated transformation); D'Halluin et al. (1992) Plant Cell 4:1495-(electroporation); Li et al. (1993) Plant Cell Reports 12:250-255 and Christou and Ford (1995) Anraals ofBotany 75:407-413 (rice); Osjoda et al. (1996) Natm°e Biotechnology 14:745-750 (maize via Agrobacterium tunaefaciens); all of which are herein incorporated by reference.
Following integration of heterologous foreign DNA into plant cells, one then applies a max -imam threshold level of glyphosate in the medium o kill the untransformed cells and separate and proliferate the putatively transformed cells that survive from this selection treatment by transferring regularly to a fresh medium. By continuous passage and challenge with glyphosate, one identifies and proliferates the cells that are transformed with the plasmid vector. Then molecular and biochemical methods will be used for confirming the presence of the integrated heterologous gene of interest in the genome of transgenic plant.
The cells that have been transformed may be grown into plants in accordance with conventional ways. See, for example, McCormick et al. (1986) Plant Cell Repof-ts 5:81-84. These plants may then be grown, and either pollinated with the same transformed strain or different strains, and the resulting hybrid having constitutive expression of the desired phenotypic characteristic identified.
Two or more generations may be grown to ensure that expression of the desired phenotypic characteristic is stably maintained and inherited and then seeds harvested to ensure expression of the desired phenotypic characteristic has been achieved. In this manner, the present invention provides transformed seed (also referred to as "transgenic seed") having a nucleotide construct of the invention, for example, an expression cassette of the invention, stably incorporated into their genome.
The present invention may be used for transformation of any plant species, including, but not limited to, monocots and dicots. Examples of plants of interest include, but are not limited to, rice, corn, alfalfa, sunflower, Bs°assica sp., soybean, cotton, safflower, peanut, sorghum, wheat, millet, and tobacco. Preferably, plants of the present invention are crop plants.
The GRG sequences of the invention may be provided in expression cassettes for expression in the plant of interest. The cassette will include 5' and 3' regulatory sequences operably linked to a sequence of the invention. By "operably linked"
is intended a functional linkage between a promoter and a second sequence, wherein the promoter sequence initiates and mediates transcription of the DNA sequence corresponding to the second sequence. Generally, operably linked means that the nucleic acid sequences being linked are contiguous and, where necessary to join two protein coding regions, contiguous and in the same reading frame. The cassette may additionally contain at least one additional gene to be cotransformed into the organism. Alternatively, the additional genes) can be provided on multiple expression cassettes.
Such an expression cassette is provided with a plurality of restriction sites for insertion of the GRG sequence to be under the transcriptional regulation of the regulatory regions.

The expression cassette will include in the 5'-3' direction of transcription, a transcriptional and translational initiation region (i.e., a promoter), a DNA
sequence of the invention, and a transcriptional and translational termination region (i.e., termination region) functional in plants. The promoter may be native or analogous, or foreign or heterologous, to the plant host and/or to the DNA sequence of the invention. Additionally, the promoter may be the natural sequence or alternatively a synthetic sequence. Where the promoter is "foreign" or "heterologous" to the plant host, it is intended that the promoter is not found in the native plant into which the promoter is introduced. Where the promoter is "foreign" or "heterologous" to the DNA sequence of the invention, it is intended that the promoter is not the native or naturally occurring promoter for the operably linked DNA sequence of the invention.
The termination region may be native with the transcriptional initiation region, may be native with the operably linked DNA sequence of interest, may be native with the plant host, or may be derived from another source (i.e., foreign or heterologous to the promoter, the DNA sequence of interest, the plant host, or any combination thereof). Convenient termination regions are available from the Ti-plasmid of A.
tunaefaciens, such as the octopine synthase and nopaline synthase termination regions.
See also Guerineau et al. (1991) Mol. Gen. Genet. 262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al. (1991) Genes Dev. 5:141-149; Mogen et al.
(1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gehe 91:151-158; Ballas et al.
(1989) Nucleic Acids Res. 17:7891-7903; and Joshi et al. (1987) Nucleic Acid Res.
15:9627-9639.
Where appropriate, the genes) may be optimized for increased expression in the transformed plant. That is, the genes can be s3mthesized using plant-preferred codons for improved expression. See, for example, Campbell and Gowri (1990) Plant Physiol. 92:1-11 for a discussion of host-preferred codon usage. Methods are available in the art for synthesizing plant-preferred genes. See, for example, U.S.
Patent Nos. 5,380,831, and 5,436,391, and Murray et al. (1989) Nucleic Acids Res.
17:477-498, herein incorporated by reference.
In one.embodiment, the nucleic acids ofinterest are targeted to the chloroplast for expression. In this manner, where the nucleic acid of interest is not directly inserted into the chloroplast, the expression cassette will additionally contain a nucleic acid encoding a transit peptide to direct the gene product of interest to the chloroplasts. Such transit peptides are known in the art. See, for example, Von Heijne et al. (1991) PlantMol. Biol. Rep. 9:104-126; Clark et al. (1989) J.
Biol.
Chem. 264:17544-17550; Della-Cioppa et al. (1987) Plant Physiol. 84:965-968;
Romer et al. (1993) Bioclaem. Biophys. Res. Commun. 196:1414-1421; and Shah et al.
(1986) Science 233:478-481. Other transit peptides include the transit peptides described in U.S. Application No. 20020073443 and U.S. Application No.
20020178467. In other embodiments, the nucleic acids of interest may be targeted to the outside of the cell or to other intracellular components, such as the nucleus, mitochondrion, or endoplasmic reticulum.
Chloroplast targeting sequences are known in the art and include the chloroplast small subunit of ribulose-1,5-bisphosphate carboxylase (Rubisco) (de Castro Silva Filho et al. (1996) Plant Mol. Biol. 30:769-780; Schnell et al.
(1991) J.
Biol. Ghem. 266(5):3335-3342); 5-(enolpyruvyl)shikimate-3-phosphate synthase (EPSPS) (Archer et al. (1990) J. Bioenerg. BiornenZb. 22(6):789-810);
tryptophan synthase (Zhao et al. (1995) J. Biol. Chem. 270(11):6081-6087); plastocyanin (Lawrence et al. (1997) J. Biol. Chem. 272(33):20357-20363); chorismate synthase ~(Schmidt et al. (1993) J. Biol. Chem. 268(36):27447-27457); and the light harvesting chlorophyll a/b binding protein (LHBP) (Lamppa et al. (1988) J. Biol. Chem.
263:14996-14999). See also Von Heijne et al. (1991) Plant Mol. Biol. Rep.
9:104-126; Clark et al. (1989) J. Biol. Chem. 264:17544-17550; Della-Cioppa et al.
(1987) Plant Physiol. 84:965-968; Romer et al. (1993) Biochem. Biophys. Res. Conamun.
196:1414-1421; and Shah et al. (1986) Science 233:478-481.
Methods for transformation of chloroplasts are known in the art. See, for example, Svab et al. (1990) P~oc. Natl. Acad. Sci. USA 87:8526-8530; Svab and Maliga (1993) P~oc. Natl. Acac~ Sci. USA 90:913-917; Svab and Maliga (1993) EMBO J. 12:601-606. The method relies on particle gun delivery of DNA
containing a selectable marker and targeting of the DNA to the plastid genome through homologous recombination. Additionally, plastid transformation can be accomplished by transactivation of a silent plastid-borne transgene by tissue-preferred expression of a nuclear-encoded and plastid-directed RNA polymerase. Such a system has been reported in McBride et al. (1994) Pf~oc. Natl. Acad. Sci. USA
91:7301-7305.

The nucleic acids of interest to be targeted to the chloroplast may be optimized for expression in the chloroplast to account for differences in codon usage between the plant nucleus and this organelle. In this manner, the nucleic acids of interest may be synthesized using chloroplast-preferred codons. See, for example, U.S.
Patent No.
5,3~0,~31, herein incorporated by reference.
Evaluation of Plant Transformation Following introduction of heterologous foreign DNA into plant cells, the transformation or integration of heterologous gene in the plant genome is confirmed by various methods such as analysis of nucleic acids, proteins and metabolites associated with the integrated gene.
PCR Analysis: PCR analysis is a rapid method to screen transformed cells, tissue or shoots for the presence of incorporated gene at the earlier stage before transplanting into the soil (Sambrook and Russell, 2001, supra) PCR is carried out using oligonucleotide primers specific to the gene of interest or Agrobacteriuna vector background, etc.
Southern Anal. skis: Plant transformation is confirmed by Southern blot analysis of genomic DNA (Sambrook and Russell, 2001, supra). In general, total DNA is extracted from the transformant, digested with appropriate restriction enzymes, fractionated in an agarose gel and transferred to a nitrocellulose or nylon membrane The membrane or "blot" then is probed with, for example, radiolabeled 32P
target DNA fragment to confirm the integration of introduced gene in the plant genome according to standard techniques (Sambrook and Russell, 2001, supra).
Northern Analysis: RNA is isolated from specific tissues of transformant, fractionated in a formaldehyde agarose gel, blotted onto a nylon filter according to standard procedures that are routinely used in the art (Sambrook and Russell, 2001, 30. supra) Expression of RNA encoded by the GRG is then tested by hybridizing the filter to a radioactive probe derived from a GRG, by methods known in the art (Sambrook and Russell, 2001, supra).

Western blot and Biochemical assays: Western blot and biochemical assays and the like may be carried out on the transgenic plants to confirm the determine the presence of protein encoded by the Glyphosate resistance gene by standard procedures (Sambrook and Russell, 2001, supra) using antibodies that bind to one or more epitopes present on the glyphosate resistance protein.
GRG-1 may be useful to provide herbicide resistance to plants In another aspect of the invention, one may generate transgenic plants expressing GRG-1 that are more resistant to high concentrations of glyphosate than non-transformed plants. Methods described above by way of example may be utilized to generate transgenic plants, but the manner in which the transgenic plant cells are generated is not critical to this invention. Methods known or described in the, art such as Ag~robacte~ium-mediated transformation, biolistic transformation, and non-particle-mediated methods may be used at the discretion of the experimenter. Plants expressing GRG-1 may be isolated by common methods described in the art, for example by transformation of callus, selection of transformed callus, and regeneration of fertile plants from such transgenic callus. In such process, GRG-1 may be used as selectable marker. Alternatively, one may use any gene as a selectable marker so long as its expression in plant cells confers ability to identify or select for transformed cells. Genes known to function effectively as selectable markers in plant transformation are well known in the art.
Fertile plants expressing GRG-1 may be tested for the ability to resist challenge with varying concentrations of glyphosate or similar herbicides, and the plants showing best resistance selected for further breeding.
GRG-1 may be used as a template to generate altered or improved variants It is recognized that DNA sequence of GRG-1 may be altered by various methods, and that these alterations may result in DNA sequences encoding proteins with amino acid sequences different that that encoded by GRG-1. This protein may be altered in various ways including amino acid substitutions,_deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants of the GRG-1 protein can be prepared by mutations in the DNA. This may also be accomplished by one of several forms of mutagenesis and/or in directed evolution. In some aspects, the changes encoded in the amino acid sequence will not substantially affect function of the protein.
Such variants will possess the desired herbicide resistance activity. However, it is understood that the ability of GRG-1 to confer glyphosate resistance may be improved by use of such techniques upon the compositions of this invention. For example, one may express GRG-1 in host cells that exhibit high rates of base misincorporation during DNA replication, such as XL-1 Red (Stratagene). After propagation in such strains, one can isolate the GRG-1 DNA (for example by preparing plasmid DNA, or by amplifying by PCR and cloning the resulting PCR fragment into a vector), culture the GRG-1 mutations in a non-mutagenic strain, and identify mutated GRG-1 genes with improved resistance to glyphosate, for example by growing cells in increasing concentrations of glyphosate and testing for clones that confer ability to tolerate increased concentrations of glyphosate.
Bacterial genes, such as the GRG-1 gene of this invention, quite often possess multiple methionine initiation codons in proximity to the start of the open reading frame. Often, translation initiation at one or more of these start codons will lead to generation of a functional protein. These start codons can include ATG codons.
However, bacteria such as Bacillus sp. also recognize the codon GTG as a start codon, and proteins that initiate translation at GTG codons contain a metluonine at the first amino acid. Furthermore, it is not often determined a p~io~i which of these codons are used naturally in the bacterium. Thus, it is understood that use of one of the alternate methionine codons may lead to generation of variants of GRG-1 (SEQ ID N0:2) that encode pesticidal activity. Thus, the altered variants arising from the use of such start codons are contained in this invention. Alternatively, alterations may be made to the protein sequence of many proteins at the amino or carboxy terminus without substantially affecting activity. This can include insertions, deletions, or alterations introduced by modern molecular methods, such as PCR, including PCR
amplifications that alter or extend the protein coding sequence by virtue of inclusion of amino acid encoding sequences in the oligonucleotides utilized in the PCR
amplification. Alternatively, the protein sequences added can include entire protein-coding sequences, such as those used commonly in the art to generate protein fusions.
Such fusion proteins are often used to (1) increase expression of a protein of interest (2) introduce a binding domain, enzymatic activity, or epitope to facilitate either protein purification, protein detection, or other experimental uses known in the art (3) target secretion or translation of a protein to a subcellular organelle, such as the periplasmic space of gram-negative bacteria, or the endoplasmic reticulum of eukaryotic cells, the latter of which often results in glycosylation of the protein.
The following examples are offered by way of illustration and not by way of limitation.
EXPERIMENTAL
Example 1. Isolation of strains resistant to ~lyphosate Glyphosate-resistant bacteria were isolated by plating samples of soil on Enriched Minimal Media (EMM) containing glyphosate as the sole source of phosphorus (EMM+G). Since EMM+G contains no aromatic amino acids, a strain must be resistant to glyphosate in order to grow on this media.
Enriched Minimal Media (,EMM) per Liter 10 g sucrose lg NH4C1 0.2 g MgZS04 7H20 0.01 g FeS04 7H20 0.007 g MnS04 H20 EMM+G
80 ml EMM
20 ml 50 mM glyphosate -adjust pH to 8.5 One particular strain, designated ATX1398, was selected due to its ability to grow in the presence of high glyphosate concentrations. ATX1398 was isolated from a sample of mushrooms. Approximately one gram of sample was added to 10 ml of EMM+G and iycubated overnight at 25 °C. I00 ~l of this culture was added to a fresh tube containing I ml of EMM+G and incubated overnight. A loopful (1 ~,1) of this culture was used to inoculate fresh lml of EMM+G. Strain ATX1398 was purified by re-streaking onto EMM agar (EMM with 15g/L agar), and re-testing for ability to grow in the presence of glyphosate. Strain ATX1398 or strain JM101 were struck onto plates of EMM agar containing SmM glyphosate. The results of this test are shown in Table 1.

Table 1. Growth of ATHX1398 in the presence of glyphosate Strain 0 mM SmM glyphosate ATX1398 +++ +++

JM101 (E.coli) +++ -Example 2. Construction of cosmid libraries Strain ATX1398 was grown in EMM, and cells were pelleted by centrifugation. Genomic DNA was extracted from ATX1398, partially digested with the enzyme Sau3A I, ligated into a cosmid vector (Supercos 1 from Stratagene) and packaged into phage particles using techniques well known in the art. An aliquot of the phage was transfected into E. coli strain JM101 (a strain known to be sensitive to glyphosate) and plated on LB agar medium containing 50 ~g/ml kanamycin to select for colonies containing cosmids.
Example 3. Isolation of clones conferring g_ly~hosate resistance upon E coli Approximately 700 kanamycin resistant colonies from genomic libraries of strain ATX1398 were replica plated onto LB-kanamycin agar, MOPS agar containing 50 ~g/ml kanamycin and 2 mM glyphosate, and MOPS agar containing 50 ~,g/ml kanamycin and 5 mM glyphosate. Four clones grew in the presence of 2 mM
glyphosate. Cosmid ATX1398(4) was observed to grow in the presence of 5 mM
glyphosate. Cosmid DNA was purified from clone ATX1398(4) and retransformed into JM101 cells using standard techniques. All resulting colonies containing the intact cosmid were resistant to 5 mM glyphosate.
A second aliquot of packaged phage was transfected into JM101 cells and plated directly onto MOPS agar medium containing 50 mg/ml kanamycin and 2 mM
glyphosate. Several glyphosate-resistant colonies were selected. One clone, cosmid ATX1398(11), was identified which conferred resistance. Restriction digest analysis of clone ATX1398(11) and comparison to restriction digest data from cosmid ATX1398(4) showed that ATX1398(4) and ATX1398(11) are independent cosmid clones that contain overlapping sections of he same genomic region.

Table 2. Glyphosate resistance conferred by cosmid clones from ATHX1398 Cosmid Clone 0 mM 2 mM glyphosate 5 mM glyphosate ATX1398(4) +++ +++ +++

ATX1398(11) +++ +++ ND

Vector alone +++ - -Example 4. Identification of GRG-1 by transposon muta~enesis To identify the genes) responsible for the glyphosate-resistance shovcnl by cosmid ATX1398(4), DNA from this clone was mutagenized with transposable elements. In this method, one identifies clones that have suffered transposon insertions, and have lost the ability to confer glyphosate resistance. The location of the transposon insertions identifies the open reading frame responsible for the glyphosate resistance phenotype.
DNA from cosmid ATX1398(4) was subjected to in-vitro transposon mutagenesis using the Primer Island Kit (PE Biosystems) and transformed into E. coli strain XL1 Blue MRF' (Stratagene) by electroporation. Clones containing a transposon insertion were selected by plating on LB agar containing 50 ~,glml carbenicillin plus 50 ~,g/ml trimethoprim, then replica plated onto MOPS agar medium containing carbenicillin, trimethoprim and 2 mM glyphosate. Three colonies were identified which contained single transposon insertions and which did not grow in the presence of 2 mM glyphosate but did grow in its absence, indicating that the .
insertions were probably in or near the gene responsible fox resistance to glyphosate.
The sequence of the DNA surrounding the transposon insertions was detemnined using methods well known in the art. The transposon insertions were all found to reside in a single open reading frame, referred to herein as GRG-1.
Cosmid ATX1398(11) was also analyzed by ih-vitro transposition and selective plating as described above.

Table 3. Mutation of GRG-1 by transposon insertion leads to loss of glyphosate resistance Clone 0 mM 2 mM glyphosate ATX1398(4) +++ +++

ATX1398(4)::TnS(4a17) +++ -ATX1398(4)::TnS(4a19) +++ -ATX1398(11) +++ +++

ATX1398(11)::TnS(1) +++ -ATX1398(11)::TnS(2) +++ -ATX1398(11)::TnS(3) +++ -Vector alone +++ -Example 5. Sequence of GRG-1 The sequence of the GRG-1 open reading frame was determined in its entirety.
Oligonucleotide primers were synthesized based on the sequence obtained from end sequences of transposon insertions. Sequencing reactions were performed using these oligonucleotide primers on clone ATX1398(4) DNA, and the resulting reactions were analyzed on an ABI 3700 automated sequencer, by methods known in the art.
Overlapping sequencing reactions were assembled to generate the DNA sequence of the open reading frame which we have designated GRG-1.
Similarly, we determined the DNA sequence from multiple transposon insertions into clone ATX1398(11). These insertions had lost the ability to confer resistance to glyphosate (Table 3). DNA sequence from the region of the transposon insertions was identical to the sequence of GRG-1 obtained from ATXI398(4).
Thus, clone ATX1398(11) also contains the GRG-1 gene, and insertions into this gene abolish the ability to confer glyphosate resistance.
Example 6. Aligmnent of GRG-I with homologous proteins We compared the predicted amino acid sequence of GRG-1 to the non-redundant database of sequences maintained by the National Center for Biotechnology Information (NCBI), using the BLAST2 algorithm (Altschul et al.
(1990) J. Mol. Biol. 215:403-410; Altschul et al. (1997) Nucleic Acids Res.
25:3389-3402; Gish and States (1993) Nature Genet. 3:266-272). BLAST algorithms compare a query sequences) for similarity to a database of known sequences and identifies sequences in the databases) with highest scoring probability of similarity.
The results of BLAST searches identified homology between the predicted GRG-1 open reading frame (SEQ ID N0:2) and several knowwnn proteins. The highest scoring amino acid sequences from this search were aligned with GRG-1 using ClustalW algorithm (Higgins et al. (1994) Nucleic Acids Res. 22:4673-4680) (as incorporated into the program ALIGNX module of the vector NTi Program Suite, Informax, Inc.). After alignment with ClustalW, the percent amino acid identity was assessed. The highest protein homology identified is a 34% amino acid identity to an EPSP synthase from Clostridium acetobutylicuna. A similar search of the patent database at NCBI
also identifies proteins with homology to GRG-l, though proteins identified in this search are less related to GRG-1. The protein with highest homology to GRG-1 in this search is the EPSP synthase of H. influenzae (SEQ ID N0:61 in US Patent No.
5,627,061), which is 25% identical to GRG-1.
The results of such searches show that GRG-1 encodes a novel protein. The protein encoded by GRG-1 has low homology to several members of the bacterial EPSP synthase enzyme family. Alignment of GRG-1 with several homologous proteins is shown in Figure 1. Though not among the highest scoring results of BLAST searches using GRG-1, it is recog~zized that GRG-1 also shares homology with several sequences in U.S. Patent No. 5,627,061 referred to therein as 'Class II' EPSP synthases, namely SEQ ID N0:3 (Agrobactef°ium sp. Strain CP4; 21 %
identity), SEQ ID NO:S (Achornobacter sp. Strain LBAA), SEQ ID N0:7 (Pseudomonas sp.
strain PG2982), SEQ ID N0:42 (Bacillus subtilis; 24% identity), and SEQ ID
NO:44 (Staphylococcus aureus). Thus, GRG-1 shows homology to a broad class of EPSP
synthases.

Table 4. Amino acid identity of GRG-1 to highest scoring EPSP synthases from a search of the translated NCBI "nr" database Organism Amino Acid Identity to GRG-Clostridium acetobutylicum 34%

Clostridium perfringens 34%

Metlaanosarca mazei 32%

Aeropyrum pernix 31%

Halobacterium NRC-1 31%

Methanosarcina acetivofans 31 Methanococcus jannushii 31 Methanopyrus kandleri 31 Fusobacterium nucleatuna 29%

Methanothermobacter thermautotfophicus28%

Asclaaeoglobus fulgidus 27%

E. coli 25%

Bacillus subtilis 24%

Agrobacterium sp. (Strain CP4) 21 Table 5. Amino acid identity of GRG-1 to highest scoring proteins from a search of NCBI patent database Organism SEQ ID Patent % amino acid Identity NO. number to GRG-H. ir~uenzae 61 US5627061 25%

S. typhimurium 4 EP0293358 25%

S. typhiynurium 3 US4769061 25%

E. coli 8 US5627061 25%

Salmonella galinarum57 US5627061 25%

K. pneumoniae S9 US5627061 25%

The amino acid sequence of GRG-1 (SEQ m N0:2) was aligned with the predicted amino acid sequences of five EPSP synthase enzymes obtained from GenBank using the ClustalW algorithm. The five sequences aligned to GRG-1 represent EPSP synthase proteins from a diverse cross section of organisms;
the monocotyledonous plant Zea nays (GenBank Accession No. X63374.1) the dicotyledonous plant A~abidopsis thaliana (GenBank Accession No. NM_1037~0.2), the bacteria E. coli (GenBank Accession No. NC 000913.1) and Agf~obacteriuna tumifaciens (GenBank Accession No. Q9R4E4) and the yeast Saccha~omyces ce~evisiae (a portion of GenBank Accession No. NC 00136.2). The alignment is shown in Figure 3. This alignment, as well as the alignments shown in Figure 1 and Figure 2, identifies several amino acids that are conserved among the EPSP
synthases shown and GRG-1. These residues are listed in Table 6.

Table 6. Alignment of GRG-1 with the five related proteins from Figure 3 Position in Position in Amino Acid GRGl Alignment G . 87 180 Example 7. Expression of GRG-1 in E. Coli GRG-1 is expressed in E, coli in the following way. First, one designs oligonucleotide primers that are homologous to each end of the gene, such that a PCR
reaction (by one skilled in the art) will result in a DNA that contains essentially all of the coding region of GRG-1. This PCR product may contain additional signal regions, such as a ribosome binding site, promoter, or sites recognized by restriction enzymes, etc. The resulting PCR reaction is cloned into a vector such as pQE60 (Invitrogen) that allows inducible protein expression. The PCR product, and cloning experiment are designed such that the resulting clone contains a proper ribosome binding site and ATG (or GTG) start codon positioned relative to the bacterial promoter (such as the Tac promoter) of the vector. The GRG-1 expressing clone is then constructed by inserting the PCR product into the expression vector by methods known in the art.
The resulting clone is placed into an E. coli cell (for example by electroporation) and colonies containing the clone identified by methods known in the art, such as selecting for an antibiotic resistance gene present in the plasmid (such as an ampicillin resistance gene). GRG-1 expression is tested by plating cells onto media containing an inducer of GRG-1 transcription (such as IPTG), and either 0 mM, 2 mM, or 5 mM
glyphosate, and assessing the ability of clones expressing GRG-1 to grow on glyphosate-containing media relative to vector controls. hl some instances, it will be preferable to perform this experiment using substantially higher concentrations of glyphosate, such as 10 mM, 20 mM or even as much as 50 mM. This is especially true when the expressed clones produce substantial quantities of enzyme. In these cases, high concentrations of glyphosate may be required to achieve sensitivity to glyphosate with control genes, such as the wild-type a~~oA of E.coli. One can quickly determine the preferred concentration of glyphosate by plating clones expressing GRG-1 and clones expressing E. coli a~oA individually onto plates that (1) allow protein expression (for example by adding IPTG to induce transcription of lac-based promoters) and (2) contain differing amounts of glyphosate (for example, 0-50 mM in 5 mM increments).

Example 8. Test of ~lyphosate resistance of GRG-1 ex~ressin~ clones vs aroA
Strains engineered to express either GRG-1 or the wild-type E. coli aroA were engineered as described in the following way. A customized expression vector, pPEH304Cm was constructed. The essential features of pPEH304Cm are the origin of replication from pBR322, a chlorarnphenicol acetyl transferase gene (for selection and maintenance of the plasmid), the lacl gene, the Ptac promoter and the YrfzB
transcriptional terminator. The GRG-1 open reading frame was amplified as described in Example 7. The oligonucleotides for PCR amplification of GRG-1 were designed to overlap the start codon of GRG-1, such that the resulting PCR
product resulted in conversion of the native GTG start.codon of GRG-1 to an ATG codon.
The a~oA open reading flame was amplified by PCR from E. coli strain XL1 Blue MRF' (Stratagene). During PCR, restriction sites were added to facilitate cloning into pPEH304Cm.
The PCR products for GRG-1 and a~oA were cloned into the expression vector pPEH304Cm to yield the plasmids pPEH306 and pPEH307, respectively, and transformed into E. coli XL1 Blue MRF'. Correct clones were identified by standard methods known in the art. The sequence of the GRG-1 and a~oA open reading frames in expression clones in pPEH306 and pPEH307 were confirmed by DNA sequencing.
Strains were grown to saturation (overnight) in Luria Broth (Sambrook and Russell, 2001, supf°a) then diluted 1:100 in M9 liquid medium (recipe) containing 0 to mM glyphosate, and supplemented with 10 g glucose, 10 mg Thiamine-HCl and 25 mg L-Proline. High level transcription from the Ptac promoter was stimulated by including O.lmM IPTG in a subset of the cultures (noted as +IPTG in Table 7).
25 SX M9 media 30 g Na2HP04 15 g I~HH2P04 5 g NH4Cl 2.5 g NaCI
30 15-mg CaCl2 Each culture was grown in a 3 ml tube at 37 °C on a culture wheel.
There were three replicate tubes of each treatment. After 8 hours of growth, 310 microliters of culture was withdrawn and placed into a 96-well plate. The absorbance of the culture at 600 nm was measured on a Spectramax 96 well plate reader. The experiment was performed in triplicate, and the values in Table 7 reflect the means of three cultures.
Table 7. Resistance of GRG-1 expressing strains to high levels of glyphosate in Luria Broth at 8 hours Glyphosate Concentration (mM) Construct 0 5 10 20 30 Vector + IPTG 0.078 0.045 0.040 0.030 0.044 GRG-1 + IPTG 0.100 0.104 0.117 0.125 0.135 aroA + IPTG 0.075 0.068 0.063 0.056 0.052 Vector 0.092 0.039 0.039 0.042 0.043 GRG-1 0.0 0.1 0.11 .112 0.104 aroA ~ _ _ _ _ 0.048 0.095 0.048 _ _ ~ ~ 0.046 ~ 0.047 ~

The data in Table 7 shows that GRG-1 encodes resistance to a high level of glyphosate, and allow not only survival, but growth of E. coli in the presence of 30 mM glyphosate. In contrast, growth of cells expressing aroA is inhibited by glyphosate concentrations of 10 mM and higher.
In addition, these strains engineered to express either GRG-1 or the wild-type E. coli aroA, were tested in another minimal media, M63, with glyphosate concentrations up to 150 mM. 1X M63 was supplemented with 10 g glucose, 10 mg Thiamine-HCl and 25 mg L-Proline. The strains were grown to saturation (overnight) in Luria Broth (Sambrook and Russell, 2001, supra) then washed two times in media (adapted from Currefzt Protocols in Molecular Biology, Greene Publishing and Wiley-Interscience, New York) before being diluted 1:100 in fresh M63 liquid medium containing 0 to 150 mM glyphosate. High level transcription from the Ptac promoter was stimulated by including 0.1 mM IPTG all of the cultures.

68g KH2P04 lOg (NH4)ZSO4 2.Smg FeS04-7Hz0 l2mg MgCl2 Each culture was grown in 2 mls of media in 10 ml tubes at 37°C in a shaker.
At 24 hours, 300 microliters of the culture was withdrawn and placed into a 96-well assay plate. The absorbance of the culture at 600 nm was measured on a Spectromax 96 well plate reader. The values in Table 8 reflect this experiment at 24 hours (NT
not tested).
Table 8. Resistance of GRG-1 expressing strains to high levels of glyphosate in M63 at 24 hours Glyphosate Concentration Construct 0 5 30 60 150 Vector + IPTG 0.5695 0.032 0.0323 0.0325 0.045 GRG-1+ IPTG 0.4943 0.7192 0.7884 0.789 0.951 a~oA + IPTG 0.5982 0.1209 0.0276 0.0298 NT
~ ~ ~ ~

Example 9. GRG-1 Complements an a~oA mutation in E. coli XL-1 MRF' cells Using PCR and recombination methods known in the art, and outlined by Datsenko and Wanner (Datsenko and Wanner (2000) P~oc. Natl. Acad. Sci. TLS.A.
97:6640-6645), an a~oA knockout strain ofE. coli XL-1 MRF' (Stratagene) was created. This system is based on the Red system which allows for chromosomal disruptions of targeted sequences. The aroA gene codes for EPSP synthase, the target enzyme for glyphosate. Therefore, by disrupting the gene, complementation of.EPSP
synthase activity could be screened for.
Using this system, 1067 bases of the 1283 bases of the aroA coding region were disrupted. The deletion of the aroA coding region was confirmed by PCR, and by complementing the deletion with a wild-type a~oA gene as described below.
EPSP synthase catalyzes the sixth step in the biosynthesis of aromatic amino acids in microbes and plants, therefore minimal media that lacks aromatic amino acids do not support growth of organisms lacking an EPSP synthase (Pittard and Wallace (I966) J. Bacteriol. 91:1494-508).
The ay~oA knockout generated above grew on LB media but did not grow on M63 minimal media. Furthermore, the knockout did grow on M63 media supplemented with phenylalanine, tryptophan, and tyrosine. These results indicate that the a~oA gene had been disrupted. Additionally, complementation was tested to ensure that the gene function could be restored. Electrocompetent cells of the knockout aYOA strain were made by traditional methods. Clone pPEH307, the expression vector containing the aroA gene, was transformed into the knockout cells and plated on LB media, M63, and M63 with amino acid supplements. The resulting transformant grew on all three media types.
To test the ability of GRG-1 to complement af~oA, plasmid pPEH306 (the expression vector containing GRG-1) was transformed into the aroA knockout cells and these cells were plated on the three types of media described above. The resulting transformant grew on all three media types. As a control, the vector pPEH304 was transformed into the aroA knockout cells and plated on LB, M63, and M63 with amino acid supplements. These cells grew on LB and M63 supplemented with aromatic amino acids, but did not grow on M63 alone. This indicates that the expression vector alone did not have the necessary components to complement the aroA mutation.
All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims. .

SEQUENCE LISTING
<110> Hammer, Philip E.
Duck, Nicholas B.
<120> Genes Conferring Herbicide Resistance <130> 045600/272010 <l50> 60/434,789 <151> 2002-12-18 <160> 2 <170> FastSEQ for Windows Version 4.0 <210> 1 <21l> 1398 <212> DNA
<213> Enterobacteriaceae <220>
<221> CDS
<222> (l03)...(139s) <400> 1 aaaaaaggaa atgaactatg tgttgctgga aaaagtaggg aagggagtgg tgaagagtat 60 tccactggtt caattagaaa aaatcattca aggattacca as gtg aaa gta aca 114 Met Lys Val Thr ata cag ecc gga gat ctg act gga att atc cag tca cec get tca aaa 162 .
Ile Gln Pro Gly Asp Leu Thr Gly T1e Ile Gln Ser Pro Ala Ser Lys agt tcg atg cag cga get tgt get get gca ctg gtt gca aaa gga ata 210 Ser 5er Met Gln Arg Ala Cys Ala Ala A1a Leu Val Ala Lys Gly Ile agt gag atc att aat ccc ggt cat agc aat gat gat aaa get gcc agg 258 Ser Glu Ile Ile Asn Pro Gly His Ser Asn Asp Asp Lys Ala Ala Arg gat att gta agc cgg ctt ggt gcc agg ctt gaa gat cag cct gat ggt 306 Asp Ile Val Ser Arg Leu Gly Ala Arg Leu Glu Asp Gln Pro Asp Gly tct ttg cag ata aca agt gaa ggc gta aaa cct gtc get cct ttt att 354 Ser Leu Gln Tle Thr Ser Glu Gly Val Lys Pro Val Ala Pro Phe Ile gac tgc ggt gaa tct ggt tta agt atc cgg atg ttt act ccg att gtt 402 Asp Cys Gly Glu Ser Gly Leu Ser Ile Arg Met Phe Thr Pro Ile Val gcg ttg agt aaa gaa gag gtg acg atc aaa gga tct gga agc ctt gtt 450 Ala Leu Ser Lys Glu Glu Val Thr Ile Lys Gly Ser G1y Ser Leu Val aca aga cca atg gat ttc ttt gat gaa att ctt ccg cat ctc ggt gta 498 Thr Arg Pro Met Asp Phe Phe Asp Glu Ile Leu Pro His Leu Gly Val aaa gtt aaa tct aac cag ggt aaa ttg cct ctc gtt ata cag ggg cca 546 RTA01/2147486v1 LysValLysSerAsnGlnGlyLysLeuProLeuValIleGlnGlyPro ttgaaaccagcagacgttacggttgatgggtccttaagctctcagttc 594 LeuLysProAlaAspValThrValAspGlySerLeuSerSerGlnPhe cttacaggtttgttgctt'gcatatgcggccgcagatgcaagcgatgtt 642 LeuThrGlyLeuLeuLeuAlaTyrAlaAlaAlaAspAlaSerAspVal gcgataaaagtaacgaatctcaaaagccgtccgtatatcgatcttaca 690 AlaIleLysValThrAsnLeuLysSerArgProTyrIleAspLeuThr l85 190 195 ctggatgtgatgaagcggtttggtttgaagactcccgagaatcgaaac 738 LeuAspValMetLysArgPheGlyLeuLysThrProGluAsnArgAsn tatgaagagttttatttcaaagccgggaatgtatatgatgaaacgaaa 786 TyrGluGluPheTyrPheLysAlaGlyAsnValTyrAspGluThrLys 2l5 220 225 atgcaacgatacaccgtagaaggcgactggagcggtggtgetttttta 834 MetGlnArgTyrThrValGluGlyAspTrpSerGlyGlyAlaPheLeu ctggtagcgggggetattgccgggccgatcacggtaagaggtttggat 882 LeuValAlaGlyAlaIleAlaGlyProIleThrValArgGlyLeuAsp atagettcgacgcaggetgataaagcgatcgttcaggetttgatgagt 930 IleAlaSerThrGlnAlaAspLysAlaIleValGlnAlaLeuMetSer gcgaacgcaggtattgcgattgatgcaaaagagatcaaacttcatcct 978 AlaAsnAlaGlyIleAlaIleAspAlaLysGluIleLysLeuHisPro getgatctcaatgcatttgaatttgatgetactgattgcccggatctt 1026 AlaAspLeuAsnAlaPheGluPl2eAspAlaThrAspCysProAspLeu tttccgccattggttgetttggcgtcttattgcaaaggagaaacaaag 1074 PheProProLeuValAlaLeuAla5erTyrCysLysGlyGluThrLys atcaaaggcgtaagcaggctggcgcataaagaaagtgacagaggattg 1122 IleLysGlyValSerArgLeuAlaHisLysGluSerAspArgGlyLeu acgctgcaggacgagttcgggaaaatgggtgttgaaatccaccttgag 1170 ThrLeuGlnAspGluPheGlyLysMetGlyValGluIleHisLeuGlu ggagatctgatgcgcgtgatcggagggaaaggcgtaaaaggagetgaa 1218 GlyAspLeuMetArgValIleGlyGlyLysGlyValLysGlyAlaGlu gttagttcaaggcacgatcatcgcattgcgatggettgcgcggtgget 1266 ValSerSerArgHisAspHisArgIleAlaMetAlaCysAlaValAla getttaaaagetgtgggtgaaacaaccatcgaacatgcagaagcggtg 1314 AlaLeuLysAlaVa1GlyGluThrThrIleGluHisAlaGluAlaVal RTA01/2147486v1 aat aaa tcc tac ccg gat ttt tac agc gat ctt aaa caa ctt ggc ggt 1362 Asn Lys Ser Tyr Pro Asp Phe Tyr Ser Asp Leu Lys Gln Leu Gly Gly 405 410 ~ 415 420 gtt gta tct tta aac cat caa ttt aat ttc tca tga 1398 Val Val Ser Leu Asn His Gln Phe Asn Phe Sex <210> 2 <21l> 431 <212> PR.T
<213> Enterobacteriaceae <400> 2 Met Lys Val Thr Ile Gln Pro Gly Asp Leu Thr Gly Ile Leu Gln Ser 1 5 10 l5 Pro Ala Ser Lys Ser Ser Met Gln Arg Ala Cys Ala Ala Ala Leu Val Ala Lys Gly Ile Ser Glu Ile Ile Asn Pro Gly His Ser Asn Asp Asp Lys Ala Ala Arg Asp Ile Val Ser Arg Leu Gly Ala Arg Leu Glu Asp Gln Pro Asp Gly Ser Leu Gln I12 Thr Ser Glu Gly Val Lys Pro Val Ala Pro Phe Ile Asp Cys Gly Glu Ser Gly Leu Ser Ile Arg Met Phe Thr Pro Ile Val Ala Leu Ser Lys Glu Glu Val Thr Ile Lys Gly Ser Gly Ser Leu Val Thr Arg Pro Met Asp Phe Phe Asp Glu Ile Leu Pro His Leu Gly Val Lys Val Lys Ser Asn Gln Gly Lys Leu Pro Leu Val Ile Gln Gly Pro Leu Lys Pro Ala Asp Val Thr Val Asp Gly Ser Leu Ser Ser Gln Phe Leu Thr Gly Leu Leu Leu Ala Tyr Ala Ala Ala Asp Ala Ser Asp Val Ala Ile Lys Val Thr Asn Leu Lys Ser Arg Pro Tyr Ile Asp Leu Thr Leu Asp Val Met Lys Arg Phe Gly Leu Lys Thr Pro Glu Asn Arg Asn Tyr Glu Glu Phe Tyr Phe Lys Ala Gly Asn Val Tyr Asp Glu Thr Lys Met Gln Arg Tyr Thr Val Glu Gly Asp Trp Ser Gly Gly Ala Phe Leu Leu Val Ala Gly Ala Ile Ala Gly Pro Ile Thr Val Arg Gly Leu Asp Ile Ala Ser Thr Gln Ala Asp Lys Ala Ile Val Gln Ala Leu Met Ser Ala Asn Ala Gly Ile Ala Ile Asp Ala Lys Glu Ile Lys Leu His Pro Ala Asp Leu Asn Ala Phe Glu Phe Asp Ala Thr Asp Cys Pro Asp Leu Phe Pro Pro Leu Val Ala Leu Ala Ser Tyr Cys Lys 305 3l0 315 320 Gly Glu Thr Lys Ile Lys Gly Val Ser Arg Leu Ala His Lys Glu Ser Asp Arg Gly Leu Thr Leu Gln Asp Glu Phe Gly Lys Met Gly Val Glu Ile His Leu Glu Gly Asp Leu Met Arg val Ile Gly Gly Lys Gly Val Lys Gly Ala Glu Val Ser Ser Arg His Asp His Arg Ile Ala Met Ala Cys Ala Val Ala Ala Leu Lys Ala Val Gly Glu Thr Thr Ile Glu His RTA01/2147486v1 Ala Glu Ala Val Asn Lys Ser Tyr Pro Asp Phe Tyr Ser Asp Leu Lys Gln Leu Gly Gly Val Val Ser Leu Asn His Gln Phe Asn Phe Ser

Claims (15)

THAT WHICH IS CLAIMED:
1. An isolated nucleic acid molecule selected from the group consisting of:
a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or a complement thereof;
b) a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID
NO:1 or a complement thereof;
c) a nucleic acid molecule that encodes a polypeptide having the amino acid sequence of SEQ ID NO:2; and d) a nucleic acid molecule that encodes a polypeptide having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2.
2. A vector comprising the nucleic acid molecule of claim 1.
3. A host cell that contains the vector of claim 2.
4. The host cell of claim 3 that is a bacterial host cell.
5. The host cell of clean 3 that is a plant host cell.
6. An isolated polypeptide selected from the group consisting of:
a) a polypeptide comprising the amino acid sequence of SEQ ID
NO:2;
b) a polypeptide having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO:2.
7. An antibody that selectively binds to a polypeptide of claim 6.
8. A plant having stably incorporated into its genome a DNA construct comprising at least one nucleotide sequence selected from the group consisting of:

a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or a complement thereof;
b) a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID
NO:1 or a complement thereof;
c) a nucleic acid molecule that encodes a polypeptide having the amino acid sequence of SEQ ID NO:2; and d) a nucleic acid molecule that encodes a polypeptide having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2.
9. The plant of claim 8, wherein said plant is selected from the group consisting of corn, alfalfa, wheat, soybean, rice, Brassica, sunflower, cotton, peanut, sorghum, millet and tobacco.
10. The plant of claim 8, wherein said plant is a monocot.
11. The plant of claim 8, wherein said plant is a dicot.
12. Seed of the plant according to claim 8.
13. A plant cell having stably incorporated into its genome a DNA
construct comprising at least one nucleotide sequence selected from the group consisting of:
a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or a complement thereof;
b) a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID
NO:1 or a complement thereof;
c) a nucleic acid molecule that encodes a polypeptide having the amino acid sequence of SEQ ID NO:2; and d) a nucleic acid molecule that encodes a polypeptide having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2.
14. A method for conferring resistance to glyphosate in a plant, comprising:
a) stably integrating into the genome of a plant cell a DNA
construct comprising a promoter operably linked to a nucleotide sequence of interest, wherein said nucleotide sequence of interest is selected from the group consisting of:
i) the nucleotide sequence set forth in SEQ NO:1;
ii) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:2; and, iii) a nucleotide sequence that is 95% identical to SEQ ID
NO:1; and b) regenerating said cell into a plant.
15. A method for conferring resistance to glyphosate in a plant cell, comprising stably integrating into the genome of said plant cell a DNA
construct comprising a promoter operably linked to a nucleotide sequence of interest, wherein said nucleotide sequence of interest is selected from the group consisting of:
a) the nucleotide sequence set forth in SEQ NO:1;
b) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:2; and c) a nucleotide sequence that is 95% identical to SEQ ID NO:1.
CA2510446A 2002-12-18 2003-12-18 Genes conferring herbicide resistance Expired - Fee Related CA2510446C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43478902P 2002-12-18 2002-12-18
US60/434,789 2002-12-18
PCT/US2003/040998 WO2004056179A2 (en) 2002-12-18 2003-12-18 Genes conferring herbicide resistance

Publications (2)

Publication Number Publication Date
CA2510446A1 CA2510446A1 (en) 2004-07-08
CA2510446C true CA2510446C (en) 2011-01-25

Family

ID=32682106

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2510446A Expired - Fee Related CA2510446C (en) 2002-12-18 2003-12-18 Genes conferring herbicide resistance

Country Status (10)

Country Link
US (3) US7405347B2 (en)
EP (1) EP1581642B1 (en)
CN (1) CN1745173B (en)
AT (1) ATE506438T1 (en)
AU (1) AU2003299832B2 (en)
BR (2) BR0317579A (en)
CA (1) CA2510446C (en)
DE (1) DE60336849D1 (en)
HK (1) HK1082271A1 (en)
WO (1) WO2004056179A2 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070197474A1 (en) * 2004-03-30 2007-08-23 Clinton William P Methods for controlling plants pathogens using N-phosphonomethylglycine
PT1885176T (en) * 2005-05-27 2016-11-28 Monsanto Technology Llc Soybean event mon89788 and methods for detection thereof
US8993846B2 (en) 2005-09-06 2015-03-31 Monsanto Technology Llc Vectors and methods for improved plant transformation efficiency
AU2006302969B2 (en) 2005-10-13 2011-09-22 Monsanto Technology, Llc Methods for producing hybrid seed
US20080313769A9 (en) 2006-01-12 2008-12-18 Athenix Corporation EPSP synthase domains conferring glyphosate resistance
WO2007103768A2 (en) 2006-03-02 2007-09-13 Athenix Corporation Methods and compositions for improved enzyme activity in transgenic plant
JP2009536819A (en) * 2006-05-12 2009-10-22 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション Enzymes for breaking down herbicides
EP2803728B1 (en) 2006-05-16 2018-11-21 Monsanto Technology LLC Use of non-agrobacterium bacterial species for plant transformation
US7855326B2 (en) 2006-06-06 2010-12-21 Monsanto Technology Llc Methods for weed control using plants having dicamba-degrading enzymatic activity
MX2008015742A (en) 2006-06-06 2008-12-19 Monsanto Technology Llc Method for selection of transformed cells.
ATE491786T1 (en) * 2006-06-09 2011-01-15 Athenix Corp NOVEL EPSP SYNTHASE GENES WITH HERBICIDE RESISTANCE
US9045765B2 (en) 2006-06-09 2015-06-02 Athenix Corporation EPSP synthase genes conferring herbicide resistance
EP2027270A2 (en) * 2006-06-13 2009-02-25 Athenix Corporation Improved epsp synthases: compositions and methods of use
US20070294785A1 (en) * 2006-06-13 2007-12-20 Athenix Corporation Methods for generating genetic diversity by permutational mutagenesis
US7939721B2 (en) * 2006-10-25 2011-05-10 Monsanto Technology Llc Cropping systems for managing weeds
US7838729B2 (en) 2007-02-26 2010-11-23 Monsanto Technology Llc Chloroplast transit peptides for efficient targeting of DMO and uses thereof
CN105219694A (en) 2007-03-09 2016-01-06 孟山都技术公司 For the preparation of plant embryo explants that transforms and purposes
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
US8158850B2 (en) * 2007-12-19 2012-04-17 Monsanto Technology Llc Method to enhance yield and purity of hybrid crops
AU2009210450A1 (en) 2008-02-01 2009-08-13 Athenix Corporation Directed evolution of GRG31 and GRG36 EPSP synthase enzymes
EP2300617B1 (en) 2008-07-16 2016-03-23 Monsanto Technology LLC Methods and vectors for producing transgenic plants
US10555527B2 (en) 2009-05-18 2020-02-11 Monsanto Technology Llc Use of glyphosate for disease suppression and yield enhancement in soybean
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
EP2525658B1 (en) 2010-01-22 2017-03-01 Bayer Intellectual Property GmbH Acaricides and/or insecticidal agent combinations
KR101982126B1 (en) 2010-03-08 2019-05-27 몬산토 테크놀로지 엘엘씨 Polynucleotide Molecules for Gene Regulation in Plants
US9593317B2 (en) 2010-06-09 2017-03-14 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
KR101995698B1 (en) 2010-06-09 2019-07-03 바이엘 크롭사이언스 엔.브이. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
EP2640706B1 (en) 2010-11-15 2017-03-01 Bayer Intellectual Property GmbH N-aryl pyrazole(thio)carboxamides
CN102174564B (en) * 2011-02-14 2013-10-30 新疆农业科学院核技术生物技术研究所 Method for obtaining genetically modified sea island cotton
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
US10538774B2 (en) 2011-08-22 2020-01-21 Basf Agricultural Solutions Seed, Us Llc Methods and means to modify a plant genome
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
BR112014005975A8 (en) 2011-09-13 2017-09-12 Monsanto Technology Llc PLANT CONTROL METHOD, METHOD OF REDUCING EXPRESSION OF A PDS GENE IN A PLANT, MICROBIAL EXPRESSION CASSETTE, METHOD OF MAKING A POLYNUCLEOTIDE, METHOD OF IDENTIFICATION OF POLYNUCLEOTIDES, AND COMPOSITIONS FOR WEED CONTROL
ES2645927T3 (en) 2011-09-13 2017-12-11 Monsanto Technology Llc Procedures and compositions for weed control
MX343071B (en) 2011-09-13 2016-10-21 Monsanto Technology Llc Methods and compositions for weed control.
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US9840715B1 (en) 2011-09-13 2017-12-12 Monsanto Technology Llc Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
MX343072B (en) 2011-09-13 2016-10-21 Monsanto Technology Llc Methods and compositions for weed control.
US9920326B1 (en) 2011-09-14 2018-03-20 Monsanto Technology Llc Methods and compositions for increasing invertase activity in plants
BR112014026203A2 (en) 2012-04-23 2017-07-18 Bayer Cropscience Nv plant-directed genome engineering
US10240161B2 (en) 2012-05-24 2019-03-26 A.B. Seeds Ltd. Compositions and methods for silencing gene expression
CN104870647A (en) 2012-10-18 2015-08-26 孟山都技术公司 Methods and compositions for plant pest control
IN2015DN04206A (en) 2012-12-19 2015-10-16 Bayer Cropscience Ag
EP2935593A2 (en) 2012-12-21 2015-10-28 Pioneer Hi-Bred International, Inc. Compositions and methods for auxin-analog conjugation
US10041068B2 (en) 2013-01-01 2018-08-07 A. B. Seeds Ltd. Isolated dsRNA molecules and methods of using same for silencing target molecules of interest
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
US10000767B2 (en) 2013-01-28 2018-06-19 Monsanto Technology Llc Methods and compositions for plant pest control
EP2971185A4 (en) 2013-03-13 2017-03-08 Monsanto Technology LLC Methods and compositions for weed control
AU2014248958A1 (en) 2013-03-13 2015-10-01 Monsanto Technology Llc Methods and compositions for weed control
BR112015023272A2 (en) 2013-03-14 2017-07-18 Pioneer Hi Bred Int plant cell, plant, plant explant, transgenic seed, method for producing a plant cell having a heterologous polynucleotide encoding a polypeptide having dicamba decarboxylase activity, method for controlling weeds in a field containing a crop and method for controlling weeds in a field containing a culture
EP2970935A1 (en) 2013-03-14 2016-01-20 Pioneer Hi-Bred International, Inc. Compositions having dicamba decarboxylase activity and methods of use
US20140283211A1 (en) 2013-03-14 2014-09-18 Monsanto Technology Llc Methods and Compositions for Plant Pest Control
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
CN105980567B (en) 2013-07-19 2021-04-16 孟山都技术有限公司 Compositions and methods for controlling phyllometaca
MX2016005778A (en) 2013-11-04 2016-12-20 Monsanto Technology Llc Compositions and methods for controlling arthropod parasite and pest infestations.
UA119253C2 (en) 2013-12-10 2019-05-27 Біолоджикс, Інк. Compositions and methods for virus control in varroa mite and bees
CN105979770B (en) 2014-01-15 2019-07-05 孟山都技术公司 For using the method and composition of the Weeds distribution of EPSPS polynucleotides
WO2015153339A2 (en) 2014-04-01 2015-10-08 Monsanto Technology Llc Compositions and methods for controlling insect pests
AU2015280252A1 (en) 2014-06-23 2017-01-12 Monsanto Technology Llc Compositions and methods for regulating gene expression via RNA interference
EP3161138A4 (en) 2014-06-25 2017-12-06 Monsanto Technology LLC Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
US10378012B2 (en) 2014-07-29 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling insect pests
JP6942632B2 (en) 2015-01-22 2021-09-29 モンサント テクノロジー エルエルシー LEPTINOTARSA control composition and its method
BR112017022000A2 (en) 2015-04-13 2018-07-03 Bayer Cropscience Ag n-cycloalkyl-n- (biheterocyclylethylene) - (thio) carboxamide derivatives.
EP3302053B1 (en) 2015-06-02 2021-03-17 Monsanto Technology LLC Compositions and methods for delivery of a polynucleotide into a plant
EP3302030A4 (en) 2015-06-03 2019-04-24 Monsanto Technology LLC Methods and compositions for introducing nucleic acids into plants
CA2992488A1 (en) 2015-08-28 2017-03-09 Pioneer Hi-Bred International, Inc. Ochrobactrum-mediated transformation of plants
US11732269B2 (en) 2015-10-02 2023-08-22 Monsanto Technology Llc Recombinant maize B chromosome sequence and uses thereof
CN109312344A (en) 2016-01-26 2019-02-05 孟山都技术公司 For controlling the composition and method of insect pest
US11732268B2 (en) 2016-06-28 2023-08-22 Monsanto Technology Llc Methods and compositions for use in genome modification in plants
CN111263810A (en) 2017-08-22 2020-06-09 纳匹基因公司 Organelle genome modification using polynucleotide directed endonucleases
CN114280306B (en) * 2021-05-27 2023-05-05 中国农业科学院植物保护研究所 ELISA detection kit and detection method for eleusine indica EPSPS protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094945A (en) * 1983-01-05 1992-03-10 Calgene, Inc. Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase, production and use
US4535060A (en) * 1983-01-05 1985-08-13 Calgene, Inc. Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use
US4971908A (en) * 1987-05-26 1990-11-20 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase
US5633435A (en) * 1990-08-31 1997-05-27 Monsanto Company Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
CN1330762C (en) * 2002-05-10 2007-08-08 北京大学 Glyphosate tolerance-5-enolpyruvoyl shikimic acid-3-phosphoric acid synthesizing enzyme and its coding genes

Also Published As

Publication number Publication date
AU2003299832B2 (en) 2009-06-18
US20080312419A1 (en) 2008-12-18
EP1581642A4 (en) 2006-06-21
EP1581642A2 (en) 2005-10-05
CA2510446A1 (en) 2004-07-08
AU2003299832A1 (en) 2004-07-14
CN1745173B (en) 2012-11-28
US20070004907A1 (en) 2007-01-04
WO2004056179A3 (en) 2005-05-26
BRPI0317579B1 (en) 2019-09-03
WO2004056179A2 (en) 2004-07-08
HK1082271A1 (en) 2006-06-02
US20040177399A1 (en) 2004-09-09
ATE506438T1 (en) 2011-05-15
EP1581642B1 (en) 2011-04-20
BR0317579A (en) 2005-11-22
DE60336849D1 (en) 2011-06-01
WO2004056179A9 (en) 2004-09-16
US7405347B2 (en) 2008-07-29
US7659376B2 (en) 2010-02-09
CN1745173A (en) 2006-03-08
US7399621B2 (en) 2008-07-15

Similar Documents

Publication Publication Date Title
CA2510446C (en) Genes conferring herbicide resistance
CA2603465C (en) Identification of a new class of epsp synthases
US7538262B2 (en) GDC-2 genes conferring herbicide resistance
US8003854B2 (en) GRG32: a novel EPSP synthase gene conferring herbicide resistance
EP1838858B1 (en) Genes conferring herbicide resistance
WO2005003362A2 (en) Methods to confer herbicide resistance
EP2327785A2 (en) EPSP synthase domains conferring glyphosate resistance
US7807881B2 (en) Methods to confer herbicide resistance
EP2027261B1 (en) Novel epsp synthase genes conferring herbicide resistance
US20070044175A1 (en) Genes conferring herbicide resistance
US20050204436A1 (en) Methods to confer herbicide resistance

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20191218